Apotex Health Corp.
APTX.TO- 1M
- +9.2%
Apotex Health Corp. in brief
Apotex Health Corp. is a listed company in the Healthcare sector, based in Canada. Its market value was $5.5 B on 31 October 2026, which makes it the 3,354th largest listed company in the world and the 122nd largest in Canada on this site. Its shares trade under the symbol APTX.TO (TSX Canada).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
Market cap history
World rank over time
Rank in Canada: #130 (Sep 2026) · #122 (Oct 2026)
Where Apotex Health Corp. operates: 1 country#
Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue.
Only the headquarters country is on file for Apotex Health Corp.: no subsidiaries, branches, offices or country revenue elsewhere in the GLEIF register, its SEC filings or Wikidata.
| Country | Presence | Revenue there |
|---|---|---|
| 🇨🇦 Canada | Headquarters | — |
Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file; map outlines from Natural Earth. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided
FDA drug approvals: Apotex Health Corp.#
374 approved applications held, 4 of them new molecular entities; 22 approvals and 1 new uses in 2026.
| Approved | Drug | Kind |
|---|---|---|
| 2026-11-09 | Tofacitinib CitrateTofacitinib Citrate · ANDA220458 | Generic drug (ANDA) |
| 2026-09-15 | EpinephrineEpinephrine · ANDA220657 | Generic drug (ANDA) |
| 2026-07-14 | Afatinib DimaleateAfatinib Dimaleate · ANDA210725 | Generic drug (ANDA) |
| 2026-06-29 | PosaconazolePosaconazole · ANDA213331 | Generic drug (ANDA) |
| 2026-06-03 | Tofacitinib CitrateTofacitinib Citrate · ANDA218096 | Generic drug (ANDA) |
| 2026-06-03 | Tofacitinib CitrateTofacitinib Citrate · ANDA220458 | Generic drug (ANDA) |
| 2026-05-12 | EverolimusEverolimus · ANDA218488 | Generic drug (ANDA) |
| 2026-05-01 | EvdiTrabectedin · NDA220837 | New drug (NDA) |
| 2026-04-30 | Sitagliptin And Metformin HydrochlorideMetformin Hydrochloride, Sitagliptin Phosphate · ANDA202426 | Generic drug (ANDA) |
| 2026-04-21 | Multiple Vitamins Injection Pediatric (Pharmacy Bulk Package)Ascorbic Acid, Biotin, Cholecalciferol, Cyanocobalamin, Dexpanthenol, Folic Acid, Niacinamide, Pyridoxine, Riboflavin, Thiamine, Tocopherol Acetate, Vitamin A, Vitamin K · ANDA210456 | Generic drug (ANDA) |
| 2026-04-21 | Multiple Vitamins Injection PediatricAscorbic Acid, Biotin, Cholecalciferol, Cyanocobalamin, Dexpanthenol, Folic Acid, Niacinamide, Pyridoxine, Riboflavin, Thiamine, Tocopherol Acetate, Vitamin A, Vitamin K · ANDA210671 | Generic drug (ANDA) |
| 2026-04-14 | CanagliflozinCanagliflozin · ANDA210449 | Generic drug (ANDA) |
| 2026-04-09 | Multiple Vitamins Injection AdultAlpha-Tocopherol Acetate, Ascorbic Acid, Biotin, Cholecalciferol, Cyanocobalamin, Dexpanthenol, Folic Acid, Niacinamide, Pyridoxine Hydrochloride, Riboflavin 5'-Phosphate Sodium, Thiamine Hydrochloride, Vitamin A Palmitate, Vitamin K · ANDA210273 | Generic drug (ANDA) |
| 2026-04-09 | Multiple Vitamins Injection AdultAlpha-Tocopherol Acetate, Ascorbic Acid, Biotin, Cholecalciferol, Cyanocobalamin, Dexpanthenol, Folic Acid, Niacinamide, Pyridoxine Hydrochloride, Riboflavin 5'-Phosphate Sodium, Thiamine Hydrochloride, Vitamin A Palmitate, Vitamin K · ANDA210672 | Generic drug (ANDA) |
| 2026-04-02 | Nintedanib EsylateNintedanib Esylate · ANDA219227 | Generic drug (ANDA) |
| 2026-03-02 | RivaroxabanRivaroxaban · ANDA218427 | Generic drug (ANDA) |
| 2026-02-23 | BrivaracetamBrivaracetam · ANDA214875 | Generic drug (ANDA) |
| 2026-02-05 | Hydrocortisone Sodium SuccinateHydrocortisone Sodium Succinate · ANDA219856 | Generic drug (ANDA) |
| 2026-02-02 | FidaxomicinFidaxomicin · ANDA219559 | Generic drug (ANDA) |
| 2026-01-30 | Emtricitabine, Rilpivirine, And Tenofovir AlafenamideEmtricitabine, Rilpivirine Hydrochloride, Tenofovir Alafenamide Fumarate · ANDA214095 | Generic drug (ANDA) |
| 2026-01-26 | PaliperidonePaliperidone · ANDA203279 | Generic drug (ANDA) |
| 2026-01-23 | Caldolornew useIbuprofen · NDA022348 (SUPPL-28) | New drug (NDA) |
| 2026-01-20 | Sitagliptin PhosphateSitagliptin Phosphate · ANDA202425 | Generic drug (ANDA) |
| 2025-11-24 | CladribineCladribine · ANDA218425 | Generic drug (ANDA) |
| 2025-11-14 | RivaroxabanRivaroxaban · ANDA208579 | Generic drug (ANDA) |
Source: Drugs@FDA (openFDA). Approvals are listed under the application's current holder (APOTEX), so they follow acquisitions
Discuss Apotex Health Corp.#
0 automatic updates and 0 member comments. Sign in to comment and react.
No posts yet. Write the first comment.
How Apotex Health Corp. compares in Healthcare
- Market cap$5.5 B · higher than 87% of 2,013
- 🇺🇸 Cogent Biosciences, Inc.$5.5 B
- 🇺🇸 Haemonetics Corporation$5.5 B
- 🇨🇳 APT Medical Inc.$5.5 B
- 🇸🇪 Sectra AB (publ)$5.5 B
- 🇺🇸 Teleflex Incorporated$5.5 B
- 🇺🇸 Doximity, Inc.$5.5 B
Peer comparison · Healthcare
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Apotex Health Corp.🇨🇦 | $5.5 B | — | — | — |
| Eli Lilly and Company🇺🇸 | $1.20 T | 43.4× | 31.9% | +44.7% |
| Johnson & Johnson🇺🇸 | $652.5 B | 40.5× | 16.2% | +6.0% |
| AbbVie Inc.🇺🇸 | $514.0 B | 49.7× | 15.7% | +8.6% |
| Roche Holding AG🇨🇭 | $370.3 B | 29.1× | 19.0% | — |
| UnitedHealth Group Incorporated🇺🇸 | $367.7 B | 23.1× | 3.5% | +11.8% |
| Merck & Co., Inc.🇺🇸 | $359.8 B | 146.7× | 3.6% | +1.3% |
| Novartis AG🇨🇭 | $286.8 B | 20.5× | 24.7% | — |
| Thermo Fisher Scientific Inc.🇺🇸 | $253.8 B | 35.9× | 14.9% | +3.9% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Compare head to head
Similar companies by size and industry
- Cogent Biosciences, Inc.$5.5 B
- Haemonetics Corporation$5.5 B
- APT Medical Inc.$5.5 B
- Sectra AB (publ)$5.5 B
- Teleflex Incorporated$5.5 B
- Doximity, Inc.$5.5 B
Sources and freshness
- Market cap:
- Oct 31, 2026
- Profile updated:
- Nov 20, 2026
Figures from Market data, value.today research, Exchange listing.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Apotex Health Corp.? Verify and update this profile — free
Show Apotex Health Corp.'s ranking on your website Get the badge
The badge updates itself as the ranking changes.